Recombinant human interferon α-2b (rh IFNα-2b) therapy for steroid resistant idiopathic thrombocytopenic purpura (ITP)

MLA

Takeo Nomura, et al. “Recombinant Human Interferon α-2b (Rh IFNα-2b) Therapy for Steroid Resistant Idiopathic Thrombocytopenic Purpura (ITP).” American Journal of Hematology, vol. 51, Jan. 1996, pp. 37–44. EBSCOhost, https://doi.org/10.1002/(sici)1096-8652(199601)51:1<37::aid-ajh7>3.0.co;2-8.

APA

Takeo Nomura, Jun-ichi Akatsuka, Kingo Fujimura, Toshiro Takafuta, Atsushi Kuramoto, Tsukasa Abe, Tatsumi Uchida, Makoto Kawakita, Shin-ichiro Kuriya, Kiyoshi Kitamura, & Kojiro Yasunaga. (1996). Recombinant human interferon α-2b (rh IFNα-2b) therapy for steroid resistant idiopathic thrombocytopenic purpura (ITP). American Journal of Hematology, 51, 37–44. https://doi.org/10.1002/(sici)1096-8652(199601)51:1<37::aid-ajh7>3.0.co;2-8

Chicago

Takeo Nomura, Jun-ichi Akatsuka, Kingo Fujimura, Toshiro Takafuta, Atsushi Kuramoto, Tsukasa Abe, Tatsumi Uchida, et al. 1996. “Recombinant Human Interferon α-2b (Rh IFNα-2b) Therapy for Steroid Resistant Idiopathic Thrombocytopenic Purpura (ITP).” American Journal of Hematology 51 (January): 37–44. doi:10.1002/(sici)1096-8652(199601)51:1<37::aid-ajh7>3.0.co;2-8.